Cure My Disease

Don't miss your cure!

 Log in / Sign up

Saliva test could spot hidden links between diabetes and gum disease

NCT ID NCT07703345

Recruiting now Knowledge-focused Sponsor: Necmettin Erbakan University Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study measures four specific substances in saliva—apelin, chemerin, ghrelin, and lipocalin 2—in people with and without type 2 diabetes and gum disease. Researchers want to see if these substances are linked to the presence or severity of these conditions. The goal is to find out if a simple saliva test could help detect or monitor gum disease and diabetes together.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If certain substances in saliva are consistently linked to gum disease and diabetes, it could lead to a simple, non-invasive saliva test to help screen for these conditions.
What could go wrong
This is an early observational study, not a treatment trial. It only looks for associations, so it cannot prove cause and effect, and the results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIODONTITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

periodontitis type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIODONTITIS TYPE 2 DIABETES MELLITUS (T2DM)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Necmettin Erbakan University Faculty of Dentistry, Department of Periodontology

    RECRUITING

    Konya, Konya, 42090, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.